DK1265900T3 - 1,5-disubstituerede 3,4-dihydro-1H-pyrimido 4,5-dpyrimidin-2-on-forbindelser og deres anvendelse ved behandling af CSBP/P38-kinasemedierede sygdomme - Google Patents

1,5-disubstituerede 3,4-dihydro-1H-pyrimido 4,5-dpyrimidin-2-on-forbindelser og deres anvendelse ved behandling af CSBP/P38-kinasemedierede sygdomme

Info

Publication number: DK1265900T3
Authority: DK; Denmark
Prior art keywords: dpyrimidin; csbp; pyrimido; disubstituted; dihydro
Prior art date: 2000-03-02

Application number

DK01914625T

Other languages

English (en)

Inventor

Jerry L Adams

Jeffrey C Boehm

Ralph F Hall

John J Taggart

Original Assignee

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-02

Filing date

2001-03-02

Publication date

2007-09-24

2001-03-02 Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp

2007-09-24 Application granted granted Critical

2007-09-24 Publication of DK1265900T3 publication Critical patent/DK1265900T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Diabetes (AREA)
Pulmonology (AREA)
Immunology (AREA)
Virology (AREA)
Neurology (AREA)
Hematology (AREA)
Dermatology (AREA)
Cardiology (AREA)
Hospice & Palliative Care (AREA)
Communicable Diseases (AREA)
Urology & Nephrology (AREA)
Heart & Thoracic Surgery (AREA)
Oncology (AREA)
Neurosurgery (AREA)
Tropical Medicine & Parasitology (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Emergency Medicine (AREA)
Psychiatry (AREA)
Endocrinology (AREA)
Molecular Biology (AREA)
Ophthalmology & Optometry (AREA)

DK01914625T 2000-03-02 2001-03-02 1,5-disubstituerede 3,4-dihydro-1H-pyrimido 4,5-dpyrimidin-2-on-forbindelser og deres anvendelse ved behandling af CSBP/P38-kinasemedierede sygdomme DK1265900T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US18641900P	2000-03-02	2000-03-02
PCT/US2001/006688 WO2001064679A1 (en)	2000-03-02	2001-03-02	1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases

Publications (1)

Publication Number	Publication Date
DK1265900T3 true DK1265900T3 (da)	2007-09-24

Family

ID=22684876

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK01914625T DK1265900T3 (da)	2000-03-02	2001-03-02	1,5-disubstituerede 3,4-dihydro-1H-pyrimido 4,5-dpyrimidin-2-on-forbindelser og deres anvendelse ved behandling af CSBP/P38-kinasemedierede sygdomme

Country Status (25)

Country	Link
EP (1)	EP1265900B1 (da)
JP (1)	JP2003525295A (da)
KR (1)	KR100806978B1 (da)
CN (1)	CN100482664C (da)
AR (2)	AR030053A1 (da)
AT (1)	ATE362473T1 (da)
AU (2)	AU3999201A (da)
BR (1)	BR0108715A (da)
CA (1)	CA2402092C (da)
CY (1)	CY1106816T1 (da)
CZ (1)	CZ20022933A3 (da)
DE (1)	DE60128457T2 (da)
DK (1)	DK1265900T3 (da)
ES (1)	ES2287107T3 (da)
HU (1)	HUP0204431A3 (da)
IL (3)	IL151426A0 (da)
MX (1)	MXPA02008588A (da)
MY (1)	MY141144A (da)
NO (1)	NO326409B1 (da)
NZ (1)	NZ520914A (da)
PL (1)	PL358280A1 (da)
PT (1)	PT1265900E (da)
TW (1)	TWI290926B (da)
WO (1)	WO2001064679A1 (da)
ZA (1)	ZA200207017B (da)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2310039T3 (es)	1998-05-26	2008-12-16	Warner-Lambert Company Llc	Pirimidinas biciclicas y 3,4-dihidropirimidinas biciclicas como inhibidores de la proliferacion celular.
US6858617B2 (en)	1998-05-26	2005-02-22	Smithkline Beecham Corporation	Substituted imidazole compounds
JP2003514899A (ja)	1999-11-23	2003-04-22	スミスクライン・ビーチャム・コーポレイション	ＣＳＢＰ／ｐ３８キナーゼ阻害剤としての３，４‐ジヒドロ−（１Ｈ）−キナゾリン−２−オン化合物
AU1783201A (en)	1999-11-23	2001-06-04	Smithkline Beecham Corporation	3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors
DE60023025T2 (de)	1999-11-23	2006-07-13	Smithkline Beecham Corp.	3,4-dihydro-(1h)chinazolin-2-on-verbindungen als csbp/p39-kinase-inhibitoren
US7235551B2 (en)	2000-03-02	2007-06-26	Smithkline Beecham Corporation	1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
IL155367A0 (en) *	2000-10-23	2003-12-23	Smithkline Beecham Corp	NOVEL 2,4,8-TRISUBSTITUTED-8h-PYRIDO[2,3,-d]PYRIMIDIN-7-ONE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, PROCESSES FOR THE PREPARATION THEREOF, AND USE THEREOF IN THE PREPARATION OF MEDICAMENTS FOR TREATING CSBP/p38 KINASE MEDIATED DISEASES
WO2002058695A1 (en) *	2000-12-20	2002-08-01	Merck & Co., Inc.	(halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
GB0124848D0 (en)	2001-10-16	2001-12-05	Celltech R&D Ltd	Chemical compounds
KR101058292B1 (ko)	2002-02-12	2011-08-22	글락소스미스클라인 엘엘씨	Ｐ38 억제제로 유용한 니코틴아미드 유도체
RU2293731C2 (ru)	2002-02-13	2007-02-20	Ф.Хоффманн-Ля Рош Аг	Производные пиридина и пиримидина, способы их получения (варианты), фармацевтическая композиция и применение
BR0309053A (pt) *	2002-04-19	2005-02-22	Smithkline Beecham Corp	Compostos
GB0214268D0 (en) *	2002-06-20	2002-07-31	Celltech R&D Ltd	Chemical compounds
PA8577501A1 (es)	2002-07-25	2004-02-07	Warner Lambert Co	Inhibidores de quinasas
GB0218800D0 (en) *	2002-08-13	2002-09-18	Celltech R&D Ltd	Chemical compounds
US7084270B2 (en)	2002-08-14	2006-08-01	Hoffman-La Roche Inc.	Pyrimido compounds having antiproliferative activity
AU2003262911A1 (en)	2002-08-29	2004-03-19	Scios Inc.	Methods of promoting osteogenesis
US7129351B2 (en)	2002-11-04	2006-10-31	Hoffmann-La Roche Inc.	Pyrimido compounds having antiproliferative activity
AU2003291310A1 (en)	2002-11-06	2004-06-03	Bristol-Myers Squibb Company	Fused heterocyclic compounds and use thereof
US7098332B2 (en)	2002-12-20	2006-08-29	Hoffmann-La Roche Inc.	5,8-Dihydro-6H-pyrido[2,3-d]pyrimidin-7-ones
WO2004089955A1 (en)	2003-04-10	2004-10-21	F.Hoffmann-La Roche Ag	Pyrimido compounds
US7244441B2 (en)	2003-09-25	2007-07-17	Scios, Inc.	Stents and intra-luminal prostheses containing map kinase inhibitors
ES2339670T3 (es) *	2003-12-23	2010-05-24	Novartis Ag	Inhibidores heterociclicos biciclicos de la quinasa p-38.
EP1828186A1 (en) *	2004-12-13	2007-09-05	Sunesis Pharmaceuticals, Inc.	Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as raf kinase inhibitors
EP1676574A3 (en)	2004-12-30	2006-07-26	Johnson & Johnson Vision Care, Inc.	Methods for promoting survival of transplanted tissues and cells
JP5201817B2 (ja) *	2005-10-28	2013-06-05	大塚製薬株式会社	医薬組成物
WO2007147104A2 (en) *	2006-06-16	2007-12-21	Glaxo Group Limited	Novel compounds
US20090318424A1 (en) *	2006-06-16	2009-12-24	Mauro Corsi	Novel compounds
KR101040394B1 (ko) *	2010-05-18	2011-06-09	(주)이성산업	역화 방지 기능을 갖는 야외용 가스 히터
CN102816162B (zh) *	2011-06-10	2016-04-27	中国科学院广州生物医药与健康研究院	嘧啶并嘧啶酮类化合物及其药用组合物和应用
TWI647220B (zh)	2013-03-15	2019-01-11	美商西建卡爾有限責任公司	雜芳基化合物及其用途
ES2892423T3 (es)	2013-03-15	2022-02-04	Celgene Car Llc	Compuestos de heteroarilo y usos de los mismos
AU2014228746B2 (en)	2013-03-15	2018-08-30	Celgene Car Llc	Heteroaryl compounds and uses thereof
CN104557872B (zh) *	2013-10-16	2017-05-24	上海璎黎药业有限公司	稠合杂环化合物、其制备方法、药物组合物和用途
WO2017151409A1 (en)	2016-02-29	2017-09-08	University Of Florida Research Foundation, Incorporated	Chemotherapeutic methods
US10342786B2 (en)	2017-10-05	2019-07-09	Fulcrum Therapeutics, Inc.	P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
PT3691620T (pt)	2017-10-05	2022-10-06	Fulcrum Therapeutics Inc	Os inibidores da quinase p38 reduzem a expressão de dux4 e genes a jusante para o tratamento de fshd
KR20240089791A (ko)	2021-10-20	2024-06-20	인실리코 메디신 아이피 리미티드	메티오닌 아데노실트랜스퍼라제 2a (mat2a) 억제제 및 그의 용도

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS60226882A (ja) *	1984-04-24	1985-11-12	Nippon Zoki Pharmaceut Co Ltd	新規ピリミドピリミジン誘導体
WO1998005661A1 (en) *	1996-08-06	1998-02-12	Pfizer Inc.	Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives
ES2310039T3 (es) *	1998-05-26	2008-12-16	Warner-Lambert Company Llc	Pirimidinas biciclicas y 3,4-dihidropirimidinas biciclicas como inhibidores de la proliferacion celular.
AU4429799A (en) *	1998-06-12	1999-12-30	Vertex Pharmaceuticals Incorporated	Inhibitors of p38
WO2000024744A1 (en) *	1998-10-23	2000-05-04	F. Hoffmann-La Roche Ag	Bicyclic nitrogen heterocycles

2001
- 2001-02-28 MY MYPI20010900A patent/MY141144A/en unknown
- 2001-02-28 AR ARP010100940A patent/AR030053A1/es unknown
- 2001-03-02 JP JP2001564176A patent/JP2003525295A/ja active Pending
- 2001-03-02 EP EP01914625A patent/EP1265900B1/en not_active Expired - Lifetime
- 2001-03-02 CZ CZ20022933A patent/CZ20022933A3/cs unknown
- 2001-03-02 AU AU3999201A patent/AU3999201A/xx active Pending
- 2001-03-02 ES ES01914625T patent/ES2287107T3/es not_active Expired - Lifetime
- 2001-03-02 AT AT01914625T patent/ATE362473T1/de active
- 2001-03-02 PT PT01914625T patent/PT1265900E/pt unknown
- 2001-03-02 DE DE60128457T patent/DE60128457T2/de not_active Expired - Lifetime
- 2001-03-02 TW TW090104783A patent/TWI290926B/zh not_active IP Right Cessation
- 2001-03-02 HU HU0204431A patent/HUP0204431A3/hu unknown
- 2001-03-02 MX MXPA02008588A patent/MXPA02008588A/es active IP Right Grant
- 2001-03-02 BR BR0108715-0A patent/BR0108715A/pt not_active Application Discontinuation
- 2001-03-02 KR KR1020027011408A patent/KR100806978B1/ko not_active Expired - Fee Related
- 2001-03-02 DK DK01914625T patent/DK1265900T3/da active
- 2001-03-02 NZ NZ520914A patent/NZ520914A/en not_active IP Right Cessation
- 2001-03-02 AU AU2001239992A patent/AU2001239992B2/en not_active Ceased
- 2001-03-02 CA CA2402092A patent/CA2402092C/en not_active Expired - Fee Related
- 2001-03-02 PL PL01358280A patent/PL358280A1/xx not_active Application Discontinuation
- 2001-03-02 CN CNB018076866A patent/CN100482664C/zh not_active Expired - Fee Related
- 2001-03-02 WO PCT/US2001/006688 patent/WO2001064679A1/en not_active Ceased
- 2001-03-02 IL IL15142601A patent/IL151426A0/xx active IP Right Grant
2002
- 2002-08-22 IL IL151426A patent/IL151426A/en not_active IP Right Cessation
- 2002-08-30 NO NO20024134A patent/NO326409B1/no not_active IP Right Cessation
- 2002-09-02 ZA ZA200207017A patent/ZA200207017B/en unknown
2003
- 2003-05-07 AR ARP030101602A patent/AR040075A2/es unknown
2007
- 2007-08-13 CY CY20071101080T patent/CY1106816T1/el unknown
2008
- 2008-02-28 IL IL189865A patent/IL189865A0/en unknown

Also Published As

Publication number	Publication date
IL151426A (en)	2011-01-31
KR20020082858A (ko)	2002-10-31
EP1265900B1 (en)	2007-05-16
PT1265900E (da)	2007-08-22
HK1052932A1 (en)	2003-10-03
MY141144A (en)	2010-03-15
NO20024134L (no)	2002-10-24
PL358280A1 (en)	2004-08-09
JP2003525295A (ja)	2003-08-26
CA2402092C (en)	2012-01-24
CZ20022933A3 (cs)	2003-02-12
AU3999201A (en)	2001-09-12
MXPA02008588A (es)	2003-02-24
IL151426A0 (en)	2003-04-10
BR0108715A (pt)	2004-04-27
EP1265900A4 (en)	2004-11-10
DE60128457T2 (de)	2008-01-17
KR100806978B1 (ko)	2008-02-25
CN100482664C (zh)	2009-04-29
AU2001239992B2 (en)	2005-09-01
ATE362473T1 (de)	2007-06-15
HUP0204431A3 (en)	2006-01-30
NZ520914A (en)	2004-03-26
CN1422273A (zh)	2003-06-04
DE60128457D1 (de)	2007-06-28
NO326409B1 (no)	2008-12-01
NO20024134D0 (no)	2002-08-30
IL189865A0 (en)	2008-08-07
ES2287107T3 (es)	2007-12-16
WO2001064679A1 (en)	2001-09-07
CA2402092A1 (en)	2001-09-07
TWI290926B (en)	2007-12-11
AR030053A1 (es)	2003-08-13
ZA200207017B (en)	2004-02-26
EP1265900A1 (en)	2002-12-18
CY1106816T1 (el)	2012-01-25
AR040075A2 (es)	2005-03-16
HUP0204431A1 (hu)	2003-04-28

Publication	Publication Date	Title
DK1265900T3 (da)	2007-09-24	1,5-disubstituerede 3,4-dihydro-1H-pyrimido 4,5-dpyrimidin-2-on-forbindelser og deres anvendelse ved behandling af CSBP/P38-kinasemedierede sygdomme
NO20024742L (no)	2002-11-25	Heterocykliske forbindelser, deres fremstilling og anvendelse
EE05507B1 (et)	2012-02-15	Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks
DK1604680T3 (da)	2010-05-10	Anvendelse af butulinumtoksin ved behandlingen af neuralgisk smerte
DK1392292T3 (da)	2006-05-29	Pyranoindazoler og deres anvendelse til behandling af glaukom
DK1047428T3 (da)	2007-10-08	Anvendelse af morpholinol til behandlingen af seksualforstyrrelser
NO20034169L (no)	2003-11-18	MCH-antagonister og deres anvendelse ved behandling av fedme
DK1122244T3 (da)	2004-10-25	Uracilforbindelser og anvendelse deraf
NO20015156L (no)	2001-12-18	5-pyridyl-1,3-azolforbindelser, deres fremstilling og anvendelse
MXPA03002813A (es)	2003-10-15	Compuestos utiles en el tratamiento de enfermedades inflamatorias.
NO20040469L (no)	2004-04-30	Heterocykliske forbindelser samt fremstilling og anvendelse derav
NO20014603L (no)	2001-11-26	Tienopyrimidinforbindelser, deres fremstilling og anvendelse
NO20011436D0 (no)	2001-03-21	2,2,6,6-dietyl-dimetyl-1-alkoksy-piperidin-forbindelser og deres korresponderende 1-oksider
DK1395567T3 (da)	2009-04-06	4-(phenylpiperazinylmethyl)-benzamidderivater og deres anvendelse til behandling af smerte, angst eller mavetarmslidelser
DK1432701T3 (da)	2006-05-08	Heterocycliske forbindelser til anvendelse ved behandlingen af lidelser i urinvejene
DK1373256T3 (da)	2005-10-10	CCR5-antagonister, der er nyttige til behandling af AIDS
DK1345598T3 (da)	2008-02-04	Anvendelsen af rosiglitazon til behandling af psykiatriske lidelser
DK1432417T3 (da)	2008-06-16	Substituerede imidazolforbindelser og deres anvendelse til behandling af cancer
IS6967A (is)	2003-09-24	Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
DK1276476T3 (da)	2006-08-14	Anvendelse af bradykardiske midler ved behandling af sygdomme i hjertemuskulaturen i forbindelse med hypertrofi, samt hedtil ukendte lægemiddelkombinationer
EE200300540A (et)	2004-02-16	4-(fenüülpiperidiin-4-ülideenmetüül)bensamiidi derivaadid, nende valmistamine ja kasutamine valu, ärevuse või seedetrakti häirete ravis
DK1252150T3 (da)	2003-09-29	Kondenserede azolderivater og deres anvendelse til sænkning af blodsukkerspejlet
NO20052699D0 (no)	2005-06-06	4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gastrointestinale lidelser.
NO20040659D0 (no)	2004-02-13	Isoksazolopyridinoner og andvendelse derav ved behandling av Parkinsons sykdom
EE200300527A (et)	2004-02-16	4-(fenüülpiperidiin-4-ülideenmetüül)bensamiidi derivaadid ja nende kasutamine valu, ärevuse või seedetrakti häirete raviks